Funded Tech Companies
Amplifier Therapeutics
Wondering who invested in Amplifier Therapeutics? Cambrian Biopharma, RA Capital Management and Future Ventures joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Amplifier Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
8911 North Capital of Texas Highway 4200
Austin, TX 78759
USA
Austin, TX 78759
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Our company Parhelia Bio provides a simple, efficient, and affordable solution to tissue auto-staining and automation for research, diagnostic, and pathology labs. We (the founders of Parhelia Bio) met at Stanford while doing our postdocs in the Nolan lab. Together we collaborated on the development of CODEX ultra--multiplexed staining technology and co-founded Akoya Biosciences (NASDAQ:AKYA) to commercialize CODEX and related methods. CODEX and Opal (later acquired by Akoya from Perkin Elmer) are now considered key technologies in the rapidly growing field of spatial biology.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
10/17/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chairman
Mike Stadnisky
Chief Executive Officer
Nikolay Samusik
Co-Founder
Yury Goltsev
Co-Founder
Garry Nolan
Company Investors
- Cambrian Biopharma
- RA Capital Management
- Future Ventures
Browse more funded tech companies:
Amplifier Security | Amplifinity
Share this article
About Our Venture Capital Transactions Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs